At a glance
ClinicalIndex Comparison RecordN/ACompleted· 131 enrolled
Drug / intervention
Cryoablationdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Multicenter Study of Metastatic Lung Tumors Targeted by Interventional Cryoablation Evaluation
In Brief
A clinical study evaluating Cryoablation for Neoplasm Metastasis. Completed, enrolled 131 participants across 10 sites in 2 countries.
Detailed Summary
The purpose of this study is to evaluate the safety and efficacy of cryoablation therapy used to treat tumors in participants with pulmonary metastatic disease. This study is to enroll participants who will undergo cryoablation of at least 1 metastatic pulmonary tumor that is less than or equal to 3.5 centimeter (cm). Participants will be followed 24 months post their cryoablation procedure.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNeoplasm Metastasis
CountriesFrance, United States
Collaborators--
Timeline
N/ACompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedOct 2013
Enrollment StartApr 2014
Primary CompletionMar 2017
Study CompletionAug 2018
TodayJul 2026
First PostedOct 8, 2013
Enrollment StartApr 10, 2014
Primary CompletionMar 9, 2017
Study CompletionAug 20, 2018
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 12.7 years ago
Interventions
Cryoablationdevice
Application of extremely cold temperatures to the identified tumor(s).